Northland raised the firm’s price target on Brainsway to $9 from $5.50 and keeps an Outperform rating on the shares as the analyst contends that the company “continues to execute on all fronts” following its Q3 report. The firm expects systems placements to remain robust, reflecting recent customer wins, rising demand, and improving access and reimbursement, the analyst tells investors in a post-earnings note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on BWAY:
- BrainsWay Reports Third Quarter 2023 Financial Results and Operational Highlights
- Brainsway reports Q3 EPS (1c) vs. (15c) last year
- BWAY Earnings this Week: How Will it Perform?
- Brainsway announces CMS published first coverage recommendation for TMS
- Brainsway announces publication of study data on Deep TMS for depression